Live Breaking News & Updates on Source nrx pharmaceuticals inc

Stay informed with the latest breaking news from Source nrx pharmaceuticals inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Source nrx pharmaceuticals inc and stay connected to the pulse of your community

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock

NRx Pharmaceuticals, Inc. , ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced the pricing of its underwritten public offering of shares of its common stock at a public offering price of $3.30 per...

New-york , United-states , France , French , Source-nrx-pharmaceuticals-inc , Nrx-pharmaceuticals-inc , Company-annual-report-on-form , Ef-hutton , Syndicate-department , Nasdaq , Exchange-commission

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , France , Paris , France-general- , Americans , American , French , Marion-leboyer , Stephen-willard , Michael-grunebaum , Mocrane-abbar , Janet-rehnquist

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT

Four potential near-term milestones, including data from two clinical trials, an NDA filing and a share dividend
RADNOR, Pa., March 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a...

France , United-states , Americans , French , Stephen-willard , Nasdaq , Therapeutics-inc , Nrx-pharmaceuticals , Source-nrx-pharmaceuticals-inc , Securities-exchange , Us-national-institutes-of-health , Us-patient-centered-outcomes-research-initiative

NRx Pharmaceuticals (NRXP) Reports Prelim FY23 Results

NRx Pharmaceuticals (NRXP) Reports Prelim FY23 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France , United-states , Americans , French , Janet-rehnquist , Stephen-willard , Nrx-pharmaceuticals-inc , Lotus , Securities-exchange , Us-patient-centered-outcomes-research-initiative , Company-board-of-directors , Nephron-pharmaceuticals

NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 -March 26, 2024 at 04:04 pm EDT

RADNOR, Pa., March 26, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that it will release its fourth quarter and full year 2023...

France , French , Nasdaq , Exchange-commission , Securities-exchange , Therapeutics-inc , Us-national-institutes-of-health , Nrx-pharmaceuticals , Nrxp-nrx-pharmaceuticals , Lotus , Prnewswire-nrx-pharmaceuticals-inc

UPDATE: Nrx Pharmaceuticals (NASDAQ: NRXP) To Report Fourth Quarter And Full Year 2023 Financial Results On March 28, 2024

UPDATE: Nrx Pharmaceuticals (NASDAQ: NRXP) To Report Fourth Quarter And Full Year 2023 Financial Results On March 28, 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

France , French , Nrxp-nrx-pharmaceuticals , Prnewswire-nrx-pharmaceuticals-inc , Nasdaq , Therapeutics-inc , Nrx-pharmaceuticals , Us-national-institutes-of-health , Prnewsfoto-nrx-pharmaceuticals-inc , Lotus , Specialty-pharmaceutical-company

NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK -March 25, 2024 at 08:31 am EDT

RADNOR, Pa., March 25, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx...

France , Radnor , Powys , United-kingdom , French , Jonathan-javitt , Nasdaq , Us-national-institutes-of-health , Prnewswire-nrx-pharmaceuticals-inc , Source-nrx-pharmaceuticals-inc , Specialty-pharmaceutical-company , Therapeutics-inc

NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales

NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France , French , Stefan-klotter , Janet-rehnquist , Division-of-enforcement , Prnewswire-nrx-pharmaceuticals-inc , Us-national-institutes-of-health , Nrx-pharmaceuticals , Exchange-commission , Securities-exchange , Nrxp-nrx-pharmaceuticals , Nrx-therapeutics-inc

NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales -March 12, 2024 at 07:50 am EDT

Initiative is intended to protect shareholder value through continued compliance with Nasdaq listing rules and elimination of naked short sales positions in the Company's securitiesThe Company is...

France , French , Janet-rehnquist , Nrx-pharmaceuticals , Exchange-commission , Prnewswire-nrx-pharmaceuticals-inc , Company-compliance-committee , Nrx-therapeutics-inc , Nasdaq , Source-nrx-pharmaceuticals-inc , Division-of-enforcement , Us-national-institutes-of-health

NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine) -March 11, 2024 at 08:31 am EDT

Company to receive first allocation of ketamine for sale by month endPartners preparing to ship IV Ketamine to full range of customers via 503a and 503b pharmaciesNRx Pharmaceuticals and HOPE...

France , French , Matthew-duffy , Exchange-commission , Nrx-pharmaceuticals , Conversio-health , Specialty-pharmaceutical-company , Source-nrx-pharmaceuticals-inc , Nrxp-nrx-pharmaceuticals , Prnewswire-nrx-pharmaceuticals-inc , Nephron-pharmaceuticals , Us-national-institutes-of-health